A medical professional showing how a knee injection should be administered.

Euflexxa’s 12-week clinical study reveals a significant satisfaction rate among patients treated for knee osteoarthritis. With 81% of patients expressing gratification with the pain relief experienced post-treatment, Euflexxa demonstrates its effectiveness in enhancing patient outcomes and elevating quality of life.

Euflexxa offers a hyaluronic acid injection for knee osteoarthritis (OA) patients with mild to moderate conditions.  It works by lubricating and cushioning the joints, which allows patients to move without pain. Among the various injection therapies available, Euflexxa distinguishes itself with a three-injection regimen. It offers an effective choice for individuals seeking relief from osteoarthritis symptoms.

This article will explore Euflexxa’s treatment, how it addresses knee osteoarthritis, its indications, and clinical applications for this three-injection therapy.

Key Takeaways

  • For individuals opting for non-surgical solutions, viscosupplementation aims to replace the HA lost in the synovial fluid to help minimize knee OA symptoms.
  • Euflexxa works in two ways to treat knee OA: it lubricates and cushions and reduces pain and inflammation.
  • As it lubricates the joint and reduces the pain, Euflexxa can diminish what knee OA causes and bring symptomatic relief to individuals.
  • Approximately 2/3 of the Euflexxa patients reported being pain-free at the end of the 12-week trial.
  • Healthcare providers must administer Euflexxa HA injections using an aseptic technique, from handling the syringe to administering the shot.
  • Euflexxa’s three-injection treatment can delay surgeries while improving the patient’s quality of life.

Introduction to Euflexxa

Ferring Pharmaceuticals Inc.'s Euflexxa injection.

Viscosupplementation therapy involves injecting hyaluronic acid (HA) into the affected joint. This substance offers a safe patient treatment, as HA naturally occurs in the body. The eyes, skin, and joints typically contain HA; this thick fluid helps reduce pain and swelling in the knee joint.

In osteoarthritis, the cartilage wears away, causing symptoms like pain, stiffness, and swelling. For individuals opting for non-surgical solutions, viscosupplementation aims to replace the HA lost in the synovial fluid to help minimize knee OA symptoms. Medical professionals may recommend this injection therapy for patients with mild to moderate knee osteoarthritis.

Fortunately, Euflexxa is a hyaluronic acid injection backed by 1% sodium hyaluronate to deliver effective knee osteoarthritis (OA) pain relief. The hyaluronic acid replenishes the lost substance in the synovial fluid, acting as a lubricant and shock absorber for the joints.

Healthcare providers may utilize Euflexxa for individuals suffering from knee OA pain who have not responded to simple analgesics or first-line therapies. Euflexxa can offer a lasting solution for these patients with its high molecular weight and linear structure of hyaluronic acid in their injection.

Mechanisms of Action

Knowing how the injection works is necessary when learning about a new treatment. Medical professionals must administer Euflexxa injections to ensure a safe and effective treatment. When knee OA occurs, the quality and quantity of synovial fluid decrease, leading to increased joint friction, pain, and inflammation.

Euflexxa works in two ways to treat knee OA: it lubricates and cushions and reduces pain and inflammation. These benefits can help increase shock absorption, protect cartilage, and help produce natural HA found in the body. This dual action makes Euflexxa an effective treatment for knee OA.

This three-injection therapy boasts sodium hyaluronate that mimics the properties of synovial fluid, a natural joint lubricant. Euflexxa supplements this fluid, restoring the joint’s lubricating and cushioning properties. This reduces pain, improves joint function, and protects the cartilage.

Indications for Euflexxa Use

An individual suffering from knee pain.

Individuals should seek medical advice before starting this Euflexxa treatment. Medical professionals can help patients determine the best treatment options for their knee OA concerns. Moreover, they can create a tailored treatment plan for individuals to achieve optimal results.

This customized treatment plan allows healthcare providers to align Euflexxa’s benefits to the patient’s needs, goals, and overall health. In this way, they can ensure that patients receive the maximum benefits of the injection treatment without compromising their health.

However, some conditions do not allow individuals to receive Euflexxa treatment. Euflexxa has not been tested on pregnant women, breastfeeding women, or children, making it a safer option to avoid therapy for this specific population. Medical professionals must explain to the patients the contraindications of the injection therapy.

  • Do not use it to treat patients with hypersensitivity to hyaluronan preparations.
  • Do not use it to treat patients with knee joint infections, infections, or skin disease in the area of the injection site.

Euflexxa can address various knee osteoarthritis symptoms that individuals experience. As it lubricates the joint and reduces the pain, Euflexxa can diminish what knee OA causes and bring symptomatic relief to individuals. If you’re one of the people feeling these symptoms, consult a doctor for a proper diagnosis.

  • Sore Joint
  • Joint Stiffness
  • Joint Pain when moving or doing everyday activities
  • Joint Pain that prevents you from exercising
  • Grating sensation when moving your joint
  • Deterioration of coordination or grip strength due to joint pain and stiffness
  • Weakened muscular strength near the affected joint
  • Conditions and symptoms that Euflexxa can address

Clinical Applications of Euflexxa

The clinical trials revealed Euflexxa injection reviews from patients who shared their high satisfaction after the treatment. In the 12-week trial versus Synvisc, 50% of the patients were delighted with Euflexxa compared to 37%. Approximately 2/3 of the Euflexxa patients reported being pain-free at the end of the 12-week trial.

On the other hand, a 26-week FLEXX trial revealed that approximately 1/2 of the Euflexxa-treated patients were pain-free at six months. Moreover, an estimated 60% better responded for less severe knee OA when treated with Euflexxa. The study also showed fewer adverse events (AEs) than saline patients. The most common AEs for Euflexxa include:

  • Arthralgia
  • Back Pain
  • Upper Respiratory Tract Infection
  • Hypertension
  • Diarrhea

Medical professionals must discuss the potential benefits of Euflexxa for symptomatic relief and functional improvement. Explaining this treatment information to the patients allows them to make informed healthcare decisions.

  • Pain Alleviation
  • Improved Mobility
  • Functional Improvement
  • Cartilage Protection
  • Delayed Surgical Intervention
  • Quality of Life

Injection Techniques and Dosing Regimens

A syringe and a vial for injection.

Euflexxa stands out among other hyaluronic acid injection brands because of its 1% sodium hyaluronate. The injection uses various potent ingredients to stabilize its formulation in addition to the HA substance.

  • Sodium Hyaluronate
  • Sodium Chloride
  • Disodium Hydrogen Phosphate Dodecahydrate
  • Sodium Dihydrogen Phosphate Dihydrate

Backed by this formulation, medical professionals must administer this injection therapy for a safe and effective process. Their expertise and skills can give individuals relief and comfort that they can perform Euflexxa injections with their broad knowledge.

Euflexxa is an injection typically administered into the synovial space of the knee joint. To achieve optimal outcomes, medical professionals should know the best practices for administering these injections and the recommended dosing regimens.

  • Administration: Healthcare providers must administer Euflexxa HA injections using an aseptic technique, from handling the syringe to administering the shot. They should also remove any joint effusion in the injection site before injecting the solution.
  • Dosing Regimen: The standard dosing of Euflexxa requires 2 mL of the solution to be injected into the affected joint at weekly intervals, totaling three injections. Euflexxa injections are single-use only, and medical professionals should use different syringes for each knee.
  • Post-Injection Care: Medical professionals know the best post-injection care for patients to achieve their desired knee OA relief results. They may require resting the knee or applying ice briefly after the injection treatment.

It’s essential to understand the entire treatment, including the dosing instructions. Staying informed about the therapy can build trust and confidence with your trusted doctor throughout the Euflexxa treatment. Furthermore, completing the course (three injections) is vital to achieve the desired goals.

In addition, medical professionals can replenish their stocks with the help of Medica Depot. They can buy Euflexxa wholesale through the trusted global supplier website and other medical and aesthetic supplies. These professionals can also receive per-unit cost discounts for their bulk purchases of Euflexxa.

Conclusion

Euflexxa offers a significant advancement in the management of knee osteoarthritis. As a hyaluronic acid injection, its formulation mimics the properties of the synovial fluid to provide lubrication and cushioning to the affected joint. Medical providers should know this mechanism of action and strictly follow the indications for use and proper administration to achieve optimal outcomes.

The clinical applications of Euflexxa have demonstrated its efficacy in reducing pain, improving joint function, and enhancing the patient’s quality of life. With a well-defined injection technique and dosing regimen, Euflexxa offers a non-surgical, effective therapy for knee OA. Its three-injection treatment can potentially delay surgeries while improving the patients’ lives.

Require assistance or custom offers?

Our sales representatives are here to help.

BOOK A MEETING

References

  1. Efficacy – Euflexxa. (n.d.). Hcp.euflexxa.com. Retrieved April 5, 2024, from https://hcp.euflexxa.com/efficacy/#12-week-trial
  2. PRODUCT INFORMATION EUFLEXXA®. (n.d.). Ferring USA. https://www.ferringusa.com/wp-content/uploads/sites/12/2024/04/EuflexxaPI-07-2016.pdf